A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2011
10/19/2011	CN102218040A Oral disintegrating tablets of microcrystallites of aripiprazole composition and preparation method thereof
10/19/2011	CN102217885A Chinese medicine pillow for treating nervous headache
10/19/2011	CN102217884A Chinese medicinal pillow
10/19/2011	CN102217879A Heart-nourishing and nerve-soothing pillow
10/19/2011	CN102217878A Gear-shifting Chinese medicine pillow
10/19/2011	CN102217876A Thyme pillow
10/19/2011	CN101904819B Method for preparing taurine particles
10/19/2011	CN101884715B Medicament for treating optic neuritis and preparation method thereof
10/19/2011	CN101696205B 3-(substituted xylylenimine-2-yl)-2,6-dioxopiperidine polymorph and pharmaceutical composition
10/19/2011	CN101370495B Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
10/19/2011	CN101304995B Thiazole derivatives and use thereof
10/19/2011	CN101006072B Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
10/18/2011	US8039647 2-amino-bicyclo (3.1.0) hexane-2,6-dicarboxylic ester derivative
10/18/2011	US8039617 Method for producing alpha form crystals of sapropterin hydrochloride
10/18/2011	US8039477 Substituted pyrazolo[3,4-d]pyrimidin-4-one compounds as phosphodiesterase inhibitors
10/18/2011	US8039461 Physical states of a pharmaceutical drug substance
10/18/2011	US8039253 Contains erythropoietin, which protectively acts on survival of oligodendrocytes, which form myelin sheath, in cerebrovascular dementia typified by multiple sclerosis and Binswanger disease
10/18/2011	US8039209 Yeast screens for treatment of human disease
10/18/2011	CA2598294C Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate derivative
10/18/2011	CA2515663C Chitosan-based transport system
10/18/2011	CA2494557C Fused heterocyclic isoxazoline derivatives and their use as anti-depressants
10/18/2011	CA2494010C Modafinil polymorphic forms
10/18/2011	CA2484038C Estrogen receptor modulators
10/18/2011	CA2480438C Novel use of the extract of processed ginseng and saponin isolated therefrom
10/18/2011	CA2478813C Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
10/18/2011	CA2475312C N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as ddp-iv inhibitors
10/18/2011	CA2470643C Cleavable reagents for specific delivery to disease sites
10/18/2011	CA2469152C Pharmaceutical composition for the treatment of parkinson's disease
10/18/2011	CA2466906C Pharmaceutical composition comprising a prostaglandin e1
10/18/2011	CA2440644C Inhibitors of integrin .alpha.v.beta.6
10/18/2011	CA2433495C Methods of examining ability to control nerve cell plasticity
10/18/2011	CA2419842C New aporphine esters and their use in therapy
10/18/2011	CA2398018C Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
10/18/2011	CA2337328C Biocompatible polymers, preparation method and compositions containing same
10/13/2011	WO2011127235A1 Combination therapy for the treatment of dementia
10/13/2011	WO2011127088A2 Methods and compositions for decreasing chronic pain
10/13/2011	WO2011126910A2 Compositions and methods for the treatment of somatosensory disorders
10/13/2011	WO2011126903A2 Multisubstituted aromatic compounds as inhibitors of thrombin
10/13/2011	WO2011126401A1 1,3-dialkyl-benzimidazole halogenides as agents for treating multiple sclerosis
10/13/2011	WO2011126324A2 Pomegranate extract having a high ellagic acid content, and use of the pomegranate extract
10/13/2011	WO2011126322A2 Composition for treating or preventing degenerative cranial nerve diseases, containing black bean extract
10/13/2011	WO2011126126A1 NON-HUMAN ANIMAL DEFICIENT IN Gm1 GENE PRODUCT AND METHOD OF UTILIZATION THEREOF
10/13/2011	WO2011126054A1 Physiologically active peptides
10/13/2011	WO2011125930A1 Prophylactic or therapeutic agent for inflammatory bowel diseases or autoimmune peripheral neuropathy
10/13/2011	WO2011125836A1 Therapeutic agent or prophylactic agent for fibromyalgia
10/13/2011	WO2011124713A1 Labelled huprine derivatives and their use in medical imaging
10/13/2011	WO2011124712A1 7,11-methanocycloocta [b] quinoline derivative as highly functionalizable acetylcholinesterase inhibitors
10/13/2011	WO2011124430A1 Tricyclic indazole compound, method of preparation and pharmaceutical composition containing it
10/13/2011	WO2011123916A1 Pharmaceutical composition for the treatment of alzheimer's disease, method for producing same and use thereof
10/13/2011	WO2011098394A3 Composition for the treatment and prevention of anxiety disorders and dyssomnia
10/13/2011	WO2011091304A9 Delivery system for diagnostic and therapeutic agents
10/13/2011	WO2011091142A3 Crystalline and amorphous forms of olanzapine pamoate
10/13/2011	WO2011070444A3 Compositions for use in methods of treating friedreich's ataxia
10/13/2011	WO2011062864A3 Inhibitors of nox enzymes and methods of use thereof
10/13/2011	WO2011056972A9 Compositions and methods of treating a t cell mediated disorder
10/13/2011	WO2011041483A9 Use of botulinum neurotoxin to treat substance addictions
10/13/2011	WO2010107435A8 A novel alpha-(n-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production
10/13/2011	US20110251288 Process for the preparation of enantiomerically pure amines
10/13/2011	US20110251286 Crystalline salts and/or co-crystals of O-desmethyltramadol
10/13/2011	US20110251274 Natural Vitamin E Compositions with Superior Antioxidant Potency
10/13/2011	US20110251267 Methods of using polynucleotides encoding truncated glial cell line-derived neurotrophic factor
10/13/2011	US20110251261 Compositions and methods for inhibition of nucleic acids function
10/13/2011	US20110251257 Methods and compositions for treating neurological disease
10/13/2011	US20110251253 Solid forms of (r)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide
10/13/2011	US20110251250 Use of dimiracetam in the treatment of chronic pain
10/13/2011	US20110251243 Method and Kit for Assessing a Patient's Genetic Information, Lifestyle and Environment Conditions, and Providing a Tailored Therapeutic Regime
10/13/2011	US20110251239 Combination therapy for the treatment of dementia
10/13/2011	US20110251238 Ppar agonist compositions and methods of use
10/13/2011	US20110251235 Stable laquinimod preparations
10/13/2011	US20110251230 Therapeutics for neurological disorders
10/13/2011	US20110251229 (+)-opioids and methods of use
10/13/2011	US20110251228 Nalmefene hydrochloride dihydrate
10/13/2011	US20110251227 Analgesic agents
10/13/2011	US20110251226 Cyclohexylamin isoquinolone derivatives
10/13/2011	US20110251225 Substituted tetrahydropyran spiro pyrrolidinone and piperidinone, preparation and therapeutic use thereof
10/13/2011	US20110251224 Spiro-oxindole compounds and their uses as therapeutic agents
10/13/2011	US20110251223 CGRP Receptor Antagonists
10/13/2011	US20110251222 Sulfone-substituted anilinopyrimidine derivatives as cdk inhibitors, the production thereof, and use as a medicine
10/13/2011	US20110251220 Pharmaceutical compositions comprising gamma secretase modulators
10/13/2011	US20110251217 Substituted purinyl-pyrazol derivatives and their use as potassium channel modulators
10/13/2011	US20110251214 Monohydrate of pardoprunox
10/13/2011	US20110251212 Piperazine derivatives
10/13/2011	US20110251211 Methods of using substituted isoxazolo pyridinones as dissociated glucocorticoids
10/13/2011	US20110251207 Biaryl-spiroaminooxazoline analogues as alpha 2c adrenergic receptor modulators
10/13/2011	US20110251204 Modulators of G Protein-Coupled Receptor 88
10/13/2011	US20110251203 Use of pkc inhibitors in diabetic complications
10/13/2011	US20110251200 Aryl guanidine f1f0-atpase inhibitors and related methods
10/13/2011	US20110251198 Methods for producing viloxazine salts and novel polymorphs thereof
10/13/2011	US20110251196 Modulators of G Protein-Coupled Receptor 88
10/13/2011	US20110251190 Spiro-tetracyclic ring compounds as beta-secretase modulators and methods of use
10/13/2011	US20110251186 Amino-Oxazines and Amino-Dihydrothiazine Compounds as Beta-Secretase Modulators and Methods of Use
10/13/2011	US20110251183 Aryl-/heteroaryl-cyclohexenyl-tetraazabenzo[e]azulenes
10/13/2011	US20110251180 Pharmaceutical agent comprising quinolone compound
10/13/2011	US20110251179 3,4-DIHYDRO-2H-PYRROLO[1,2-a]PYRAZIN-1-ONE DERIVATIVES
10/13/2011	US20110251175 Stigmine Conjugates for Substance Use Disorders
10/13/2011	US20110251172 Purine derivatives for treatment of alzheimer's disease
10/13/2011	US20110251171 Heterocyclic compounds and methods of use
10/13/2011	US20110251169 Arylethynyl derivatives
10/13/2011	US20110251166 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta2 adrenergic receptor
10/13/2011	US20110251165 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta2 adrenergic receptor

1 ... 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 ... 1833